Today’s Biotech Movers: Raptor Pharma, Horizon Pharma and Foamix Pharma http://marketexclusive.com/todays-biotech-movers/32363/?icd1

RPTP bullish 7.28

TTM Squeeze scan

Raptor Pharmaceuticals Corp. RPTP was a big mover last session, as the company saw its shares rise roughly 6% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $5.73 to $6.89 over the past one month time frame.

This Med/Biomed gene industry stock witnessed one positive estimate revision over the past 30 days. The Zacks Consensus Estimate also moved up over the same time frame, suggesting that more solid trading could be ahead for Raptor Pharmaceuticals. So make sure to keep an eye on this stock going forward to see if yesterday’s jump can turn into more strength down the road.

Raptor Pharmaceuticals has a Zacks Rank #2 (Buy).


http://finance.yahoo.com/news/raptor-pharmaceuticals-rptp-focus-stock-120512446.html

$8.67 p/m. Wow

Thanks guys

Thank you

2 bidders now...

https://www.bloomberg.com/news/articles/2016-08-17/retrophin-said-to-consider-bid-for-raptor-pharmaceutical

Dig a bit deeper. $7.87 close :)))

When was that tweet? I don't see any mention doing a Google search.

$RPTP $7.40 from $6.80 and $7 buys pic.twitter.com/n8X564GABn

— ClearlyStocks (@ClearlyStocks) August 17, 2016

Do you have a link? The only thing I found was from April and that said $7-8 a share... http://www.fool.com/investing/general/2016/04/07/raptor-pharmaceutical-stock-upgraded-3-things-you.aspx

$800 million aka $11 per share

Buyout offer here? Hmmmmm

$7.70 boom! Another buyout! $800 million.

In at $7 long on chatter

In a

may be ready for 5.50 pivot,,,hold tite bio sector reversing

Looking for gap up in the morning

Resistance at 4.05 and new micro support at 4.00

We need to break thru the resistance at 4.05 to hit the next level.

I wanted and intended to flip 1000 shares ,but it still showing signs of strong upward movement.

Guess I'll hold the total 2g shares n watch closely for any break down below support which is currently at 3.93 .

This baby is holding strong and just keeps moving upward in a steady
slow methodical pace.

In at $3.55 ,oh yeah !

I'll flip 1000 shares and hold 1000 if it continues...due to the great news out.

Monday’s Movers and Shakers in Biotech - article mentions Raptor

http://marketexclusive.com/mondays-movers-and-shakers-in-biotech-2/1169/

The Latest Raptor Announcement May Be More Positive Than Markets Think

http://marketexclusive.com/the-latest-raptor-announcement-may-be-more-positive-than-markets-think/1161/

Liftoff $$$$$ myop

may break $6.50 today $$$$$$myop

$RPTP recent news/filings

bearish 6.08

## source: finance.yahoo.com

Mon, 16 Nov 2015 12:34:22 GMT ~ NIDDK Provides Additional Data From CyNCh Study Evaluating RP103 in Pediatric NASH at AASLD

[at noodls] - NOVATO, Calif., Nov. 16, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (NASDAQ:RPTP) today announced researchers have provided additional results from the CyNCh study of RP103 for the treatment ...

read full: http://www.noodls.com/view/81A0C05D8366F30FBBD6D3BFD16EFFEBFCBA02F2
*********************************************************

Mon, 16 Nov 2015 12:07:00 GMT ~ 7:07 am Raptor Pharma provides additional results on RP103, re-iterating there was no difference in the response rate between RP103 and placebo


read full: http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#rptp
*********************************************************

Mon, 16 Nov 2015 12:05:00 GMT ~ NIDDK Provides Additional Data From CyNCh Study Evaluating RP103 in Pediatric NASH at AASLD

[GlobeNewswire] - NOVATO, Calif. -- Raptor Pharmaceutical Corp. (NASDAQ:RPTP) today announced researchers have provided additional results from the CyNCh study of RP103 for the treatment of children 8 to 17 years with biopsy-confirmed ...

read full: http://finance.yahoo.com/news/niddk-provides-additional-data-cynch-120500935.html
*********************************************************

Fri, 13 Nov 2015 18:04:28 GMT ~ RAPTOR PHARMACEUTICAL CORP Financials


read full: http://finance.yahoo.com/q/is?s=rptp
*********************************************************

Sun, 08 Nov 2015 19:08:02 GMT ~ Edited Transcript of RPTP earnings conference call or presentation 5-Nov-15 9:30pm GMT


read full: http://finance.yahoo.com/news/edited-transcript-rptp-earnings-conference-190802660.html
*********************************************************

$RPTP charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com



$RPTP company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/RPTP/company-info
Ticker: $RPTP
OTC Market Place: Not Available
CIK code: not found
Company name: Raptor Pharmaceutical Corp.
Incorporated In: DE, USA

Business Description:

$RPTP share structure

## source: otcmarkets.com

Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: No Par Value

$RPTP extra dd links

Company name: Raptor Pharmaceutical Corp.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/RPTP/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/RPTP/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=RPTP+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=RPTP+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=RPTP+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/RPTP/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/RPTP/news - http://finance.yahoo.com/q/h?s=RPTP+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/RPTP/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/RPTP/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/RPTP/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/RPTP/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/RPTP/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/RPTP/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/RPTP/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/RPTP/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=RPTP+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/RPTP
DTCC (dtcc.com): http://search2.dtcc.com/?q=Raptor+Pharmaceutical+Corp.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Raptor+Pharmaceutical+Corp.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Raptor+Pharmaceutical+Corp.&x=0&y=0

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/RPTP/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/RPTP
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/RPTP/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/RPTP/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/RPTP/sec-filings
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/RPTP/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/RPTP/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/RPTP/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/RPTP/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=RPTP&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=RPTP
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/RPTP/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=RPTP+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=RPTP+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=RPTP
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=RPTP
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=RPTP+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/RPTP/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=RPTP+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/RPTP.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=RPTP
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/RPTP/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/RPTP/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/RPTP/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/RPTP/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/RPTP
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/RPTP
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/RPTP:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=RPTP
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=RPTP



$RPTP DD Notes ~ http://www.ddnotesmaker.com/RPTP

sweet news,rasing outlook bigtime plenty of cash $$$$$

i never like when conference calls and earnings are after mrkt close,,may not be good,,anyone have a clue on that

funny how ihub boards get quite when they about to surge $$$$$$

We go,,rlyp,rptp,aqxp,apri,ttph,kbio,mcur,uppppppp,myop

SCANNERALERT! JUST HIT THE STICKSANDWICH ON THE SCAN!!!

BULLISH IMO!!

$7+ today spikes big nxt week,,myop

& yesterday! I loaded up Wed @ $5.67

Steal! Think we see $10 by eoy

Big day today

NEWS ,,http://biz.yahoo.com/e/151005/rptp8-k.html

adding $$$$$$ myop

Picked up 800 more today on the lows,imo we are pretty much at bottom.Time for them to have some good news by the end of the year!!

she wants to run,,squeezzzzzzzzzzz myop

* * $RPTP Video Chart 09-14-15 * *

Link to Video - click here to watch the technical chart video

Thank god

$RPTP recent news/filings

bullish

## source: finance.yahoo.com

Wed, 10 Jun 2015 18:36:00 GMT ~ Street Talk: RPTP under the radar


read full: http://finance.yahoo.com/video/street-talk-rptp-under-radar-183600926.html
*********************************************************

Wed, 10 Jun 2015 12:26:20 GMT ~ Coverage initiated on Raptor Pharma by Citigroup


read full: http://finance.yahoo.com/q/ud?s=RPTP
*********************************************************

Thu, 28 May 2015 12:06:13 GMT ~ Raptor Pharmaceutical to Participate in Upcoming Investor Conferences

[at noodls] - NOVATO, Calif., May 28, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq: RPTP) today announced that Julie Anne Smith, President and Chief Executive Officer, will present at the following investor ...

read full: http://www.noodls.com/view/1D9A0DEF37C83B08CE2861F9A01C9751A52F0FE5
*********************************************************

Thu, 28 May 2015 11:30:00 GMT ~ Raptor Pharmaceutical to Participate in Upcoming Investor Conferences

[GlobeNewswire] - NOVATO, Calif. -- Raptor Pharmaceutical Corp. (Nasdaq: RPTP) today announced that Julie Anne Smith, President and Chief Executive Officer, will present at the following investor conferences:

read full: http://finance.yahoo.com/news/raptor-pharmaceutical-participate-upcoming-investor-113000630.html
*********************************************************

Wed, 20 May 2015 20:03:35 GMT ~ RAPTOR PHARMACEUTICAL CORP Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a


read full: http://biz.yahoo.com/e/150520/rptp8-k.html
*********************************************************

$RPTP charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com



$RPTP company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/RPTP/company-info
Ticker: $RPTP
OTC Market Place: Not Available
CIK code: not found
Company name: Raptor Pharmaceutical Corp.
Incorporated In:

Business Description:

$RPTP share structure

## source: otcmarkets.com

Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: No Par Value

$RPTP extra dd links

Company name: Raptor Pharmaceutical Corp.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/RPTP/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/RPTP/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=RPTP+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=RPTP+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=RPTP+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/RPTP/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/RPTP/news - http://finance.yahoo.com/q/h?s=RPTP+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/RPTP/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/RPTP/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/RPTP/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/RPTP/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/RPTP/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/RPTP/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/RPTP/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/RPTP/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=RPTP+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/RPTP
DTCC (dtcc.com): http://search2.dtcc.com/?q=Raptor+Pharmaceutical+Corp.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Raptor+Pharmaceutical+Corp.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Raptor+Pharmaceutical+Corp.&x=0&y=0

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/RPTP/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/RPTP
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/RPTP/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/RPTP/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/RPTP/sec-filings
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/RPTP/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/RPTP/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/RPTP/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/RPTP/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=RPTP&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=RPTP
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/RPTP/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=RPTP+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=RPTP+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=RPTP
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=RPTP
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=RPTP+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/RPTP/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=RPTP+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/RPTP.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=RPTP
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/RPTP/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/RPTP/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/RPTP/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/RPTP/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/RPTP
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/RPTP
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/RPTP:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=RPTP
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=RPTP



$RPTP DD Notes ~ http://www.ddnotesmaker.com/RPTP

$RPTP is about to break out here big time - long set up through 9.60 with volume _ im long

#NOLIMITS

Loading up got some 8s last week

This CO. Is the real deal

Does this company really have the cure for liver disease?


16:41 ET 8/11/14 [StreetAccount] ICPT Follow-up x2: Intercept details FLINT trial data in 10Q ($237.18)

Company states that:
"NIDDK recently provided us with a draft manuscript intended for publication that describes the results from the FLINT trial. As the manuscript is in draft form and is expected to undergo peer review, it is subject to further modification prior to publication. The top-line information about the FLINT trial results described below is based on the draft manuscript provided to us by NIDDK."
Highlights from the data:
Secondary Efficacy Endpoints:
More patients in the OCA treatment group also experienced improvements in the following histological secondary endpoints (n=200):
All the individual components of NAS improved in OCA-treated patients (p-values ranged from 0.03 to <0.001 for each component vs. placebo);
NASH resolution: 22% of OCA-treated patients vs. 13% of patients on placebo (p=0.09); and
Fibrosis improvement (scored 0 – 4): 35% of OCA-treated patients vs. 19% of patients on placebo (p=0.01);
Decrease in mean value of 0.2 from a baseline mean of 1.9 in OCA-treated patients vs. increase in mean value of 0.1 from baseline mean of 1.8 in patients on placebo (p=0.01).
Metabolic Parameters:
OCA treatment was associated with the following changes in metabolic parameters at 72-weeks (n=257).
Statistically significant weight loss in patients on OCA treatment compared to patients in the placebo group (p=0.008);
Increase in a marker of fasting hepatic insulin resistance, HOMA-IR, in the OCA treatment group (p=0.01), although an even larger increase was observed in the placebo group at the conclusion of the 24-week follow-up phase; and
No changes in hemoglobin A1c over a period of approximately three months, in either OCA or placebo groups.
Serum Lipids:
OCA treatment was associated with changes in serum lipid levels that were observed within 12 weeks of initiating treatment (the first time point assessed), then decreased in magnitude while on treatment and effectively returned to baseline during the 24-week post-treatment period
Safety and Tolerability:
The draft FLINT manuscript reported that OCA was generally well tolerated based on the safety and tolerability data from all 283 patients randomized in the trial. The incidence of adverse events in the OCA and placebo treatment groups was similar for all symptoms except pruritus, which occurred more frequently (23% vs. 6%, p<0.001) and at a higher grade (predominantly moderate pruritus). One patient discontinued due to pruritus in the OCA treatment arm.
The incidence of severe or life threatening events was not different between the two treatment groups and most of the events in both groups were deemed to be unrelated to treatment, including all severe or life threatening cardiovascular events. There were two patient deaths in the trial that were previously disclosed in our 10K; neither death was considered related to OCA treatment.
Stock resumed trading at 16:40ET +47% to $350



*****Related comments from the archive:


11-Aug-14 16:24 ET
ICPT Follow-up: Intercept issues press release on Q2 results; provides business update ($237.18)

Note StreetAccount reported earnings from the company's 10-Q moments ago (see linked comments)
Summary of Key Development Programs, Updates and Anticipated Milestones:
NASH Program
FLINT trial data provided in 10-Q filing and to be discussed on today's conference call
The proportion of patients meeting the FLINT primary histological endpoint, defined as a decrease in the NAFLD Activity Score (NAS) of at least two points with no worsening of fibrosis, was 46% in the OCA treatment group and 21% in the placebo treatment group (p < 0.001, n=219).
Subgroup analyses showed a numerically higher response rate in OCA-treated patients with more advanced NASH, as assessed by NAS, fibrosis staging or co-morbid type 2 diabetes.
The mean pre-treatment baseline NAS for patients in the OCA treatment group was 5.3 of a total possible score of 8 (comprised of hepatocellular ballooning 0 – 2, lobular inflammation 0 – 3 and steatosis 0 – 3).
Further details can be viewed in the company's 10-Q (linked below), under the section "Recent Developments"
Phase 3 program initiation anticipated in 1H 2015, pending regulatory feedback
Phase 2 lipid metabolism trial initiation anticipated in 1H 2015
PBC Program
Phase 3 confirmatory trial protocol finalization anticipated in 3Q 2014 and initiation planned around year-end 2014
Pre-NDA and pre-MAA meetings anticipated in 4Q 2014 with completed filings anticipated in 1H 2015
Primary Sclerosing Cholangitis (PSC) Double-blind phase 2 trial initiation anticipated year-end 2014
INT-767 Phase 1 Trial Initiation Anticipated in 1H 2015
ICPT shares are halted; to resume trading at 16:40ET


* * * * *

11-Aug-14 16:16 ET
ICPT Intercept Pharmaceuticals reports Q2 GAAP EPS $1.51 vs year-ago ($0.79) -- 10-Q ($237.18)

Reports Q2:
Reported EPS includes $55.8M gain on revaluation of warrants
Net Income $33.5M vs year-ago ($13.5M)
R&D expense $14.9M vs year-ago $5.1M
Cash and equivalents $45.0M vs year-ago $13.4M


* * * * *

11-Aug-14 16:01 ET
ICPT Intercept Pharmaceuticals shares halted; news pending ($237.18)

Note the company is scheduled to report earnings this afternoon.


* * * * *




StreetAccount alert for portfolio(s):
· CORE (ICPT)
· CLIENT (ICPT)

Tickers mentioned in/related to this story; follow link for 30-day news history: ICPT


--------------------------------------------------------------------------------

Contact us: reply to this email with questions, comments, or corrections, or call us at 617.261.5200

Website: www.streetaccount.com | Download StreetAccount for iOS from the App Store

Copyright (C) 2014 StreetAccount LLC | POB 13453, Jackson WY 83002 | 1541906.635432915919063


--------------------------------------------------------------------------------

This message, and any attachments, is for the intended recipient(s) only, may contain information that is privileged, confidential and/or proprietary and subject to important terms and conditions available at http://www.bankofamerica.com/emaildisclaimer. If you are not the intended recipient, please delete this message.

Raptor Pharmaceutical Corp. [$RPTP] due diligence

bullish
completed a 50% fibonacci retracement from the June impulse rally
should bounce to 15 to 20 initially as it rallies
could be forming a cup and handle pattern also



$RPTP

DD Notes ~ http://www.ddnotesmaker.com/RPTP

##### recent news/filings ~ source: finance.yahoo.com

Tue, 08 Jul 2014 20:10:09 GMT ~ Raptor Pharmaceuticals CEO to Retire, Appoints Successor
read full: http://finance.yahoo.com/news/raptor-pharmaceuticals-ceo-retire-appoints-201009699.html
*********************************************************

Tue, 08 Jul 2014 19:33:11 GMT ~ RAPTOR PHARMACEUTICAL CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Ex
read full: http://biz.yahoo.com/e/140708/rptp8-k.html
*********************************************************

Mon, 07 Jul 2014 20:08:51 GMT ~ Raptor Announces CEO Succession Plan; Dr. Christopher Starr to Retire as CEO at Year-end 2014, Julie Anne Smith Named President and CEO-Designate
[at noodls] - NOVATO, Calif., July 7, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceuticals (Nasdaq:RPTP) today announced that Julie Anne Smith, Executive Vice President, Strategy and Chief Operating Officer at Raptor, has ...
read full: http://www.noodls.com/view/64C3DB57101512A4CB02F504FD9AE07D32E5FD36
*********************************************************

Mon, 07 Jul 2014 20:05:42 GMT ~ Raptor Pharmaceuticals appoints Julie Anne Smith as president, CEO
read full: http://www.theflyonthewall.com/permalinks/entry.php/RPTPid2034220/RPTP-Raptor-Pharmaceuticals-appoints-Julie-Anne-Smith-as-president-CEO
*********************************************************

Mon, 07 Jul 2014 20:01:00 GMT ~ Raptor Announces CEO Succession Plan; Dr. Christopher Starr to Retire as CEO at Year-end 2014, Julie Anne Smith Named President and CEO-Designate
[GlobeNewswire] - NOVATO, Calif. -- Raptor Pharmaceuticals today announced that Julie Anne Smith, Executive Vice President, Strategy and Chief Operating Officer at Raptor, has been named President and CEO-designate effective ...
read full: http://finance.yahoo.com/news/raptor-announces-ceo-succession-plan-200100885.html
*********************************************************

##### chart ~ source: stockcharts.com




##### company info ~ source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/RPTP/company-info
Ticker: $RPTP
OTC Market Place: Not Available
CIK code: not found
Company name: Raptor Pharmaceutical Corp.
Incorporated In:

##### extra dd links

Latest filings: http://www.otcmarkets.com/stock/RPTP/filings
Latest financials: http://www.otcmarkets.com/stock/RPTP/financials
Latest news: http://www.otcmarkets.com/stock/RPTP/news - http://finance.yahoo.com/q/h?s=RPTP+Headlines

Major holdings: http://data.cnbc.com/quotes/RPTP/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=RPTP+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/RPTP.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=RPTP

RegSho: http://www.regsho.com/tools/symbol_stats.php?sym=RPTP&search=search

DTCC: http://search2.dtcc.com/?q=Raptor+Pharmaceutical+Corp.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&q=Raptor+Pharmaceutical+Corp.
Corporation WIKI: http://www.corporationwiki.com/search/results?term=Raptor+Pharmaceutical+Corp.&x=0&y=0

Short Sales: http://www.otcmarkets.com/stock/RPTP/short-sales
Insider Disclosure: http://www.otcmarkets.com/stock/RPTP/insider-transactions
Research Reports: http://www.otcmarkets.com/stock/RPTP/research
Historical Prices: http://finance.yahoo.com/q/hp?s=RPTP+Historical+Prices
Basic Tech. Analysis: http://finance.yahoo.com/q/ta?s=RPTP+Basic+Tech.+Analysis
Company Profile: http://finance.yahoo.com/q/pr?s=RPTP+Profile
Key Statistics: http://finance.yahoo.com/q/ks?s=RPTP+Key+Statistics
Industry: http://finance.yahoo.com/q/in?s=RPTP+Industry
Insider Roster: http://finance.yahoo.com/q/ir?s=RPTP+Insider+Roster
Income Statement: http://finance.yahoo.com/q/is?s=RPTP
Balance Sheet: http://finance.yahoo.com/q/bs?s=RPTP
Cash Flow: http://finance.yahoo.com/q/cf?s=RPTP+Cash+Flow&annual
Market Watch: http://www.marketwatch.com/investing/stock/RPTP
Bloomberg: http://www.bloomberg.com/quote/RPTP:US
Morningstar: http://quotes.morningstar.com/stock/s?t=RPTP
Bussinessweek: http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=RPTP
Barchart: http://www.barchart.com/quotes/stocks/RPTP
OTC Short Report: http://otcshortreport.com/index.php?index=RPTP
Investopedia: http://www.investopedia.com/markets/stocks/RPTP/?wa=0

http://www.pennystocktweets.com/stocks/profile/RPTP

##### last known share structure ~ source: otcmarkets.com

Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: No Par Value

##### business description ~ source: otcmarkets.com



DD Notes ~ http://www.ddnotesmaker.com/RPTP
a11k

These Nasdaq / Amex option spreads on relative micro cap Cos are usually skewed, that's why one needs to make as certain as possible that the strike price will actually be hit. With tighter, more correlated pps to options price moving symbols, just a lil move toward strike can be a nice pay day.

correction: considering RPTP call options - but the spreads are wide... liking that it seems to have held over it's support

considering RPTP call options - but the spreads are wide... liking that it seems to have held near it's resistance

Putting in a nice reversal candle today, time to roll IMO